To capture the pathological signature in cell lines, we compared the miRNAs expression profile of six BL and two MCL cell lines (of these, one with known MYC overexpression) with normal B-cell populations at diverse differentiation stages, ranging from bone marrow CD34+ cells to mature post GC activated B-cells from tonsils (Figure 3). This evidence concerns the gene CD34 and Burkitt lymphoma.